Latest News

The pharmaceutical firm Vivus has announced that their chief executive officer Leland Wilson will present an overview of the company next week, where they are expected to give an update on a variety of new treatments, including a product to combat hypoactive sexual desire disorder in women...

Valentine’s Day has just been and across the world, millions of men tried to charm the women in their life with extravagant gifts of chocolate...

The recent decision of the European Medicines Agency to withdraw the slimming pill Reductil from sale has left a lot of patients feeling bereft...

Boehringer Ingelheim, the drugs company researching the potential of the new medication flibanserin, are currently recruiting women suffering from hypoactive sexual desire disorder (HSDD) to take part in clinical trials into the drug in the US...

They say abstinence is the best way to prevent the spread of sexually transmitted infections and for 1 in 4 women over 35, they are certainly playing their part to keep the STI rates down...